Oligometastatic disease has been proposed as an intermediate state between localised and
systemically metastasised disease. In the absence of randomised phase 3 trials, early …

Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC)
cases. We performed a review and meta-analysis to evaluate survival after resection of CRC …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Colon Cancer focuses on systemic therapy options for the treatment of metastatic …

PURPOSE To provide expert guidance to clinicians and policymakers in resource-
constrained settings on the management of patients with late-stage colorectal cancer …

Colon Cancer in: Journal of the National Comprehensive Cancer Network Volume 7 Issue 8
(2009) Jump to Content User Account Sign In to save searches and organize your favorite …

INTRODUCTION Agents that promote tissue regeneration could be beneficial in a variety of
clinical settings, such as stimulating recovery of the hematopoietic system after bone marrow …

Background This study aimed to provide information on timing, anatomical location, and
predictors for metachronous metastases of colorectal cancer based on a large consecutive …

Colon cancer is believed to arise from two types of precursor polyps via two distinct
pathways: conventional adenomas by the conventional adenoma-to-carcinoma sequence …

The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical
management, perioperative treatment, posttreatment surveillance, management of recurrent …

Objective: To examine the impact of surgical margin width on survival following R0 hepatic
resection for colorectal metastases (CRLM). Summary of Background Data: Although …